C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding C4 Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 121 | 100 | −21 |
| Shares | 37.4M | 34.2M | −3.16M (−8.4%) |
| Value | $117.5M | $94.1M | −$23.4M (−19.9%) |
New holders (15)
Institutions that held C4 Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nantahala Capital Management, LLC | 1,000,000 | $2.75M | 0.33% |
| Aquilo Capital Management, LLC | 760,657 | $2.09M | 1.37% |
| Acadian Asset Management LLC | 128,060 | $351.0K | 0.00% |
| Bridgeway Capital Management, LLC | 100,000 | $275.0K | 0.01% |
| Algert Global LLC | 59,070 | $162.4K | 0.01% |
| State of Wyoming | 34,494 | $94.9K | 0.03% |
| Prelude Capital Management, LLC | 34,000 | $93.5K | 0.01% |
| Graham Capital Management, L.P. | 32,974 | $90.7K | 0.00% |
| Old Mission Capital LLC | 29,548 | $81.3K | 0.00% |
| Laurion Capital Management LP | 25,983 | $71.5K | 0.00% |
| DRW Securities, LLC | 21,100 | $58.0K | 0.00% |
| Pale Fire Capital SE | 19,200 | $52.8K | 0.01% |
| Jump Financial, LLC | 17,915 | $49.3K | 0.00% |
| Balyasny Asset Management LLC | 11,686 | $32.1K | 0.00% |
| Engineers Gate Manager LP | 10,900 | $30.0K | 0.00% |
Sold out (36)
Institutions that held C4 Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.